Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution’s high-risk population-Reference-Cited by-同舟云学术

Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution’s high-risk population

Published:2018-12 Issue: Volume:82 Page:20-31
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Meiss Alice E.,Thomas Martha,Modesitt Susan C.,Ring Kari L.,Atkins Kristen A.,Mills Anne M.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management;Kleibl;Breast,2016

2. Associations between cancer predisposition testing panel genes and breast cancer;Couch;JAMA Oncol,2017

3. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort;Masciari;Breast Cancer Res Treat,2012

4. CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer;Stefansson;Epigenetics,2011

5. Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families;Eerola;Breast Cancer Res,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi‐gene panel analysis in BRCA1/2‐negative patients suspected of hereditary breast and ovarian cancer syndrome: Real‐world data from a single institution;Journal of Obstetrics and Gynaecology Research;2024-07-30

2. BRCA1 Intragenic Duplication Combined with a Likely Pathogenic TP53 Variant in a Patient with Triple-Negative Breast Cancer: Clinical Risk and Management;International Journal of Molecular Sciences;2024-06-06

3. Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer?;Cancers;2024-01-11

4. Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer model;Nanomedicine;2022-05

5. Li–Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype–phenotype correlation;BMC Medical Genomics;2022-03-04